We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Wyss-designed Swabs Enter Human Trials for COVID-19

News   Apr 28, 2020 | Original story from The Wyss Institute for Biologically Inspired Engineering at Harvard University

 
Wyss-designed Swabs Enter Human Trials for COVID-19

Credit: Pixabay

 
 
Advertisement
 

RELATED ARTICLES

Hydroxychloroquine Trial Revived by WHO as Doubt Cast on Lancet, NEJM Studies

News

Testing of the malaria drug hydroxychloroquine as a treatment for COVID-19 has been restarted by the WHO after researchers raised concerns about the paper, published in The Lancet two weeks ago, that first suggested the drug was linked to reduced survival and a higher risk of heart-related side effects.

READ MORE

Researchers Develop New Way To Detect Blood Clots

News

Researchers in the Department of Biomedical Engineering at Texas A&M University are working on an entirely new way to detect blood clots, especially in pediatric patients.

READ MORE

Small Study Demonstrates Sample Inactivation May Lead to SARS-CoV-2 False Negatives

News

To protect medical laboratory personnel from infection when testing clinical samples for SARS-CoV-2, most laboratories inactivate the virus before testing. In a recent study, researchers tested several inactivation methodologies to determine if and to what extent they reduce detectable virus in a clinical sample.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE